EMB-07

EMB-07 · EpimAb Biotherapeutics (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for EMB-07, covering 2025-03-03 to 2026-02-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the EMB-07 Combination Therapy in Patients With Aggressive B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

See pricing